Page 12 - Pfizer

Pfizer Ltd net profit rises 9% to Rs 143 crore in September quarter

The drug firm on Wednesday reported an 8.81% rise in net profit

'Turning point': Pfizer vaccine gets final nod for children over five

CDC Director Rochelle Walensky recommended the vaccine for children from 5 to 11 years old

Stocks to Watch: SBI, Airtel, SpiceJet, Trent, Mtar, Pfizer, HPCL, Bata

SBI and other banking shares, along with stocks of companies to report earnings today will be in focus

US gives final clearance to Pfizer's Covid-19 shots for kids 5 to 11

The decision marks the first opportunity for Americans under 12 to get the powerful protection of any COVID-19 vaccine.

US CDC advisors recommend Pfizer's Covid-19 vaccine for children aged 5-11

The vaccine is one-third the adult dose and the it would be given in two doses, three weeks apart. The lower dose was chosen to minimize side effects and still produce strong immunity, said Pfizer.

Third Pfizer vax dose more effective in reducing severe Covid: Lancet

A third vaccine dose of Pfizer-BioNTech is effective in reducing severe Covid related outcomes compared to individuals who have received two vaccine doses at least five months ago, finds a new study.

FDA paves way for Pfizer Covid-19 vaccinations in young kids

A few countries have begun using other COVID-19 vaccines in children under 12, including China, which just began vaccinations for 3-year-olds

US FDA advisers back Pfizer-BioNTech Covid-19 vaccine for children

The companies have said their vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children aged 5 to 11

US FDA says Pfizer Covid-19 vaccine looks effective for young kids

Federal health regulators said late Friday that kid-size doses of Pfizer's COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children

Pfizer says its Covid vaccine is 91% effective in kids of ages 5 to 11

The efficacy result is based on a trial of about 2,250 children, according to the briefing documents

US FDA clears Moderna, J&J booster shots; backs Covid-19 vaccine mixing

Pfizer and BioNTech said a booster shot of their Covid-19 vaccine restored full protection in a large study, results that are likely to bolster the argument for giving a third dose more widely

Top headlines: RIL shareholders approve Saudi appointment; setback for Zee

Business Standard brings you the top stories from today

Pfizer says its booster shot is 95.6% effective against symptomatic Covid

Regulators have wrestled with how widely to use boosters as the fast-spreading delta variant drives infection rates up

Pfizer-BioNTech ask EU agency to approve vaccine for kids 5-11

Pharmaceutical company Pfizer and biotechnology company BioNTech said Friday they have requested to have their coronavirus vaccine licensed for children ages 5 to 11 across the European Union

Pfizer asks US govt to allow Covid vaccine shots for kids ages 5 to 11

Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 -- and if regulators agree, shots could begin within a matter of weeks. Many parents and pediatricians are clamoring for protection for children younger than 12, today's age cutoff for the vaccine made by Pfizer and its German partner BioNTech. Not only can youngsters sometimes get seriously ill, but keeping them in school can be a challenge with the coronavirus still raging in poorly vaccinated communities. Pfizer announced in a tweet that it had formally filed its application with the Food and Drug Administration. Now the FDA will have to decide if there's enough evidence that the shots are safe and will work for younger children like they do for teens and adults. An independent expert panel will publicly debate the evidence on Oct. 26. One big change: Pfizer says its research shows the younger kids should get a third of the dose now given to everyone else. After their second .

Pfizer vaccine effective against Covid hospitalisations for 6 months: Study

The study was published in The Lancet journal on Tuesday

Covid-19 pandemic: EU panel backs booster shots of Pfizer, Moderna

Those ages 18 and older can get a third dose of the Pfizer vaccine, developed with BioNTech SE, at least six months after their second shot, the European Medicines Agency said in a statement Monday

Pfizer to sell Upjohn business to Mylan Pharma for Rs 180.48 crore

The transaction in India will be closed upon receipt of regulatory approvals, Pfizer Ltd said

2 doses of Pfizer vax may protect kids from long Covid: Study

The US Food and Drug Administration (FDA) has approved two doses of Pfizer-BioNTech Covid-19 vaccine to be administered to children ages 12 through 15, 21 days apart.

Pfizer Covid-19 vaccine for kids may not be available until November

Pfizer has submitted research to the U.S Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November